Marcampo, Rosemia A.
HRN: 04-83-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2022
CEFUROXIME 500MG (TAB)
07/20/2022
07/26/2022
ORAL
500mg
BID
Increased WBC 20
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes